Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Asieris, Caliway, Foresee, Hutchmed, Innocare, J Ints, Sinovac,Takeda, Urovant.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Broncus, Nevro .

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acticor, Harpoon, Neurobo, Zynerba.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anavex, Asieris, Biohaven, Coeptis, Edgewise, Scilex, Vincerx.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ondine Biomedical, Organon.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alzheon, AN2, Asieris, Caliway, Dalcor, Eiger, Horizon, Imcyse, Innocare, J Ints, Kyverna, Moderna, Nektar, Ocugen, Q32, Regulus, Tme.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Affluent Medical, Lunit, Nemaura Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Acelyrin, Aerami, Aim, Algo, Altimmune, Anokion, Artiva, Arrowhead, Astrazeneca, Avalyn, Curevac, Day One, Dianthus, Foresee, GSK, Humacyte, Hutchmed, IO Biotech, Lisata, Lyra, Mindmed, Myeloid, Neurocrine, Nextcure, Nuvectis, Ose, Replicate, RS Oncology, Sorrento, Sparrow, Valbiotis, Vistagen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Mainz Biomed, Theranica.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: ACM Biolabs.